Belt and Suspenders: Vaccines and Tixagevimab/Cilgavimab for Prevention of COVID-19 in Immunocompromised Patients

被引：17
|
作者：
Kotton, Camille N. [1 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Div Infect Dis, 55 Fruit St,Cox 5, Boston, MA 02114 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2022年 / 175卷 / 06期
关键词：
D O I：
10.7326/M22-1026
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：892 / +
页数：4
相关论文
共 50 条
  • [31] Cilgavimab/tixagevimab unlikely to be active against some COVID-19 Omicron subvariants
    Reactions Weekly, 2023, 1941 (1) : 1 - 1
  • [32] Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients
    Lombardi, Andrea
    Viero, Giulia
    Villa, Simone
    Biscarini, Simona
    Palomba, Emanuele
    Azzara, Cecilia
    Iannotti, Nathalie
    Mariani, Bianca
    Genovese, Camilla
    Tomasello, Mara
    Tonizzo, Anna
    Fava, Marco
    Valzano, Antonia Grazia
    Morlacchi, Letizia Corinna
    Donato, Maria Francesca
    Castellano, Giuseppe
    Cassin, Ramona
    Carrabba, Maria
    Muscatello, Antonio
    Gori, Andrea
    Bandera, Alessandra
    BIOMEDICINES, 2023, 11 (06)
  • [33] In persons at risk for poor vaccination response or COVID-19 exposure, tixagevimab plus cilgavimab reduced COVID-19
    Aisenberg, Gabriel M.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (08) : JC92 - JC92
  • [34] Genotypic and predicted phenotypic analysis of SARS-COV-2 Omicron subvariants in immunocompromised patients with COVID-19 following tixagevimab-cilgavimab prophylaxis
    Ordaya, Eloy E.
    Vergidis, Paschalis
    Razonable, Raymund R.
    Yao, Joseph D.
    Beam, Elena
    JOURNAL OF CLINICAL VIROLOGY, 2023, 160
  • [35] COST-EFFECTIVENESS OF AZD7442 (TIXAGEVIMAB AND CILGAVIMAB) FOR PRE-EXPOSURE PROPHYLAXIS AGAINST COVID-19 IN THE IMMUNOCOMPROMISED POPULATION
    Sutton, K.
    Miller, P.
    Branscombe, N.
    Mittal, M.
    Browne, C.
    Arnetorp, S.
    Henry, T.
    Breslin, K.
    Bungey, G.
    Quint, J.
    Montgomery, H.
    VALUE IN HEALTH, 2022, 25 (12) : S168 - S168
  • [36] Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies
    Reimann, Patrick
    Petzer, Verena
    Muendlein, Axel
    Hartmann, Bernd
    Severgnini, Luciano
    Winkler, Alex
    Lang, Theresia
    Huynh, Minh
    Gasser, Klaus
    Rueger, Julia
    Atzl, Michele
    Mink, Sylvia
    Fraunberger, Peter
    Schmidt, Stefan
    Steiner, Normann
    Griesmacher, Andrea
    Gunsilius, Eberhard
    Nachbaur, David
    Willenbacher, Wolfgang
    Wolf, Dominik
    Winder, Thomas
    Benda, Magdalena Anna
    ANNALS OF HEMATOLOGY, 2024, 103 (06) : 2123 - 2131
  • [37] Accelerated cell culture process development and characterization for cilgavimab/tixagevimab (AZD7442) for the prevention and treatment of COVID-19
    Handlogten, Michael W.
    Bosley, Stefanie
    Dunn, Sarah
    Zhu, Jie
    Lee-O'Brien, Allison
    Li, Lina
    Therres, Jamy
    Chakrabarti, Lina
    Khanal, Bijay
    Mowery, Rachel
    Arumugam, Subhashini
    Klover, Judith
    Taleb, Mohammed
    Reier, Jason
    Hatton, Diane
    Schmelzer, Albert
    BIOTECHNOLOGY AND BIOENGINEERING, 2023,
  • [38] Clinical characteristics and COVID-19-related outcomes of immunocompromised patients receiving tixagevimab/cilgavimab pre-exposure prophylaxis in Japan
    Taniguchi, Toshibumi
    Homma, Tomoyuki
    Tamai, Yoichi
    Arita, Yoshifumi
    Fujiwara, Masakazu
    Kuroishi, Naho
    Sugiyama, Keiji
    Kanazu, Shinichi
    Maruyama, Atsushi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2025, 31 (01)
  • [39] Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study
    Vergori, Alessandra
    Matusali, Giulia
    Cimini, Eleonora
    Bordi, Licia
    Borrelli, Paola
    Lanini, Simone
    Palazzi, Roberta
    Paulicelli, Jessica
    Mariotti, Davide
    Mazzotta, Valentina
    Notari, Stefania
    Casetti, Rita
    Francalancia, Massimo
    Rosati, Silvia
    D'Abramo, Alessandra
    Mija, Cosmina
    Mencarini, Paola
    Milozzi, Eugenia
    Caraffa, Emanuela
    Sica, Simona
    Metafuni, Elisabetta
    Sora, Federica
    Rago, Angela
    Siniscalchi, Agostina
    Abruzzese, Elisabetta
    Garzia, Mariagrazia
    Luzi, Giovanni
    Battistini, Roberta
    Prosperini, Luca
    Cingolani, Antonella
    Girardi, Enrico
    Maggi, Fabrizio
    Antinori, Andrea
    VACCINES, 2024, 12 (07)
  • [40] The effect of tixagevimab-cilgavimab on clinical outcomes in patients with COVID-19: A systematic review with meta-analysis
    Wang, Yong
    Zheng, Jun
    Zhu, Kongfu
    Xu, Chengshi
    Wang, Daping
    Hou, Mengzhuo
    JOURNAL OF INFECTION, 2023, 86 (01) : E15 - E17
12345